Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark G. Foletta currently holds 6,331 shares of AMYLIN PHARMACEUTICALS INC (AMLN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark G. Foletta has been a net seller of AMLN stock. They have purchased $176.3K and sold $8.7M worth of shares.
Mark G. Foletta's most recent insider trade was on May 28, 2026, when they sold 6,331 shares at $0.00 per share.
Mark G. Foletta serves as Executive at AMYLIN PHARMACEUTICALS INC (AMLN). They have executed 236 insider transactions totaling $8.9M over their tenure at the company.
Mark G. Foletta holds the position of Executive at AMYLIN PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Mark G. Foletta has shown a selling trading pattern, with $176.3K in total purchases and $8.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mark G. Foletta was on Apr 11, 2023, when they sold $420.5K worth of AMN shares. This transaction involved 4,989 shares at $84.29 per share.
Mark G. Foletta currently owns 6,331 shares of AMYLIN PHARMACEUTICALS INC (AMLN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark G. Foletta's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark G. Foletta has 236 Form 4 filings on record as an insider at AMYLIN PHARMACEUTICALS INC.
Set alerts for Mark G. Foletta and 40,000+ other insiders.